Friday, March 14, 2025
spot_img

Martela Corporation’s Annual Report 2024 published

Martela Corporation, Annual Financial Report, 13.3.2025 at 10.00 a.m.

Martela Corporation’s year 2024 Board of Directors’ Report, Financial Statements, Auditor’s report, Corporate Governance Statement and Remuneration report has been published today. All of the above statements are attached to this release as PDF and XHTML files and are also available on Martela’s website www.martela.com. They are available in Finnish and English.

The Financial Statements in accordance with European Single Electronic Format (ESEF) reporting requirements are published in Finnish and English. In line with the ESEF requirements, the primary financial statements, notes and the company’s identification data have been labelled with iXBRL tags. The audit firm Ernst & Young Oy has provided an independent auditor’s reasonable assurance report on the ESEF Financial Statements.

Martela Corporation
Henri Berg
CFO
tel. +358 40 836 5464

Distribution
NASDAQ Helsinki
Main news media
www.martela.com

Martela is a Nordic leader specialising in user-centric working and learning environments. We create the best places to work and offer our customers the Martela Lifecycle solutions which combine furniture and related services into a seamless whole.

Attachments

  • Remuneration Report 2024
  • 743700M4EIEVD61PNN55-2024-12-31-en
  • Martela_Annual_Report_2024

Powered by SlickText.com

Hot this week

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Topics

NORBIT – Awarded NOK 260 million orders

Trondheim, 14 March 2025: NORBIT today announces that segment...

Transaction in Own Shares

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14...

Idorsia announces the publication of positive data with daridorexant in patients with chronic insomnia and nocturia

Daridorexant, Idorsia’s dual orexin receptor antagonist, shows consistent efficacy...

Parsons to Present at the Bank of America Global Industrials Conference

CHANTILLY, Va., March 13, 2025 (GLOBE NEWSWIRE)...
spot_img

Related Articles

Popular Categories

spot_img